Hair Million promotes hair growth in both women and men. It is made of healthy and safe herbs that have been well documented and in use for thousands of years, especially in Asia. Although these herbs have not yet been scientifically proven by placebo-controlled clinical trials nor the ingedients of the herbs charaterized in laboratory, the herbal formula has been proven efficacious anecdotally in a number of people who experience hair thinning and hair loss. There are other herbs and nutritions that also work in anecdotal cases. For instance, Saw palmetto fruit extract have beens shown effective. Other herbs, such as sage, evening primrose, horse chestnut, horsetail, rosemary have been suggested. B vitamins, especially biotin might help as well.

Hair Million is a finest product that would ward off hair loss and promote hair growth, without side effect. Hair Million should be orally taken as suggested for a few months to see the positive effects: stopping hair thinning, and hair loss, and observing new hair growth. For some individuals, none of the hair growth products or methods would work, and the reasons are not always clear. People with alopecia areata would certainly benefit from Hair Million. Once you know it works for you, you could take it for months and years. It often results in complete restoration of hair.



  • Striae distensae - like lesions. A cause of scarring alopecia among children.
  • The hydraulic influence in androgen-related hair growth: implications in autoimmune disease.
  • Relationship between irreversible alopecia and exposure to cyclophosphamide, thiotepa and carboplatin (CTC) in high-dose chemotherapy.
  • Effect of minoxidil on hair growth in androgenic alopecia in women
  • Mouse models for human hair loss disorders.
  • Notch/RBP-J Signaling Regulates Epidermis/Hair Fate Determination of Hair Follicular Stem Cells.
  • Langerhans cells that express matrix metalloproteinase 9 increase in human dermis during sensitization to diphenylcyclopropenone in patients with alopecia areata.
  • Defolliculated (dfl): a dominant mouse mutation leading to poor sebaceous gland differentiation and total elimination of pelage follicles.
  • Role of the Autoimmune Regulator (AIRE) gene in alopecia areata: Strong association of a potentially functional AIRE polymorphism with alopecia universalis.
  • Disappearance of pili annulati following an episode of alopecia areata.
  • Treatment of alopecia areata with diphencyprone
  • TrichoScan. A new instrument for digital hair analysis
  • Curly bare (cub), a new mouse mutation on chromosome 11 causing skin and hair abnormalities, and a modifier gene (mcub) on chromosome 5.
  • Seventeen cases of alopecia areata: combination of SADBE topical immunotherapy with other therapies.
  • Fas and c-kit are involved in the control of hair follicle melanocyte apoptosis and migration in chemotherapy-induced hair loss.
  • Female pattern hair loss.
  • The potential role of minoxidil in the hair transplantation setting.
  • Vitamin D3 analogs stimulate hair growth in nude mice.
  • 'Cyclic alopecia' in Msx2 mutants: defects in hair cycling and hair shaft differentiation.
  • Notch/RBP-J Signaling Regulates Epidermis/Hair Fate Determination of Hair Follicular Stem Cells.
  • Defolliculated (dfl): a dominant mouse mutation leading to poor sebaceous gland differentiation and total elimination of pelage follicles.
  • Nutritional factors and hair loss.
  • Notch/RBP-J Signaling Regulates Epidermis/Hair Fate Determination of Hair Follicular Stem Cells.
  • Adverse health effects of selenium in humans.
  • Postmenopausal frontal fibrosing alopecia.
  • Androgenetic alopecia
  • Gene array profiling and immunomodulation studies define a cell-mediated immune response underlying the pathogenesis of alopecia areata in a mouse model and humans.
  • Comparative efficacy of various treatment regimens for androgenetic alopecia in men.
  • Acute Diffuse and Total Alopecia of the Female Scalp. a new subtype of diffuse alopecia areata that has a favorable prognosis.
  • Androgenetic alopecia
  • Relationship between irreversible alopecia and exposure to cyclophosphamide, thiotepa and carboplatin (CTC) in high-dose chemotherapy.
  • Steroidogenic isoenzymes in human hair and their potential role in androgenetic alopecia.
  • Hair Transplantation for Men with Advanced Degrees of Hair Loss
  • Curly bare (cub), a new mouse mutation on chromosome 11 causing skin and hair abnormalities, and a modifier gene (mcub) on chromosome 5.
  • Weekly administration of paclitaxel and pirarubicine for recurrent breast cancer
  • Curly bare (cub), a new mouse mutation on chromosome 11 causing skin and hair abnormalities, and a modifier gene (mcub) on chromosome 5.
  • Weekly administration of paclitaxel and pirarubicine for recurrent breast cancer
  • Mouse models for human hair loss disorders.
  • Relationship between irreversible alopecia and exposure to cyclophosphamide, thiotepa and carboplatin (CTC) in high-dose chemotherapy.
  • Assessment of hair loss: clinical relevance of hair growth evaluation methods.
  • Curly bare (cub), a new mouse mutation on chromosome 11 causing skin and hair abnormalities, and a modifier gene (mcub) on chromosome 5.
  • Notch/RBP-J Signaling Regulates Epidermis/Hair Fate Determination of Hair Follicular Stem Cells.
  • TrichoScan. A new instrument for digital hair analysis
  • Alopecia universalis in a case of systemic lupus erythematosus.
  • Gene array profiling and immunomodulation studies define a cell-mediated immune response underlying the pathogenesis of alopecia areata in a mouse model and humans.
  • Fas and c-kit are involved in the control of hair follicle melanocyte apoptosis and migration in chemotherapy-induced hair loss.
  • Androgen-inducible TGF-beta1 from balding dermal papilla cells inhibits epithelial cell growth: a clue to understand paradoxical effects of androgen on human hair growth.
  • Disappearance of pili annulati following an episode of alopecia areata.
  • Defolliculated (dfl): a dominant mouse mutation leading to poor sebaceous gland differentiation and total elimination of pelage follicles.
  • Steroidogenic isoenzymes in human hair and their potential role in androgenetic alopecia.
  • The hair follicle as a target for gene therapy
  • The pattern and profile of alopecia areata in Singapore - a study of 219 Asians.
  • Loss of cell adhesion in Dsg3bal-Pas mice with homozygous deletion mutation (2079del14) in the desmoglein 3 gene.
  • Efficacy and tolerance of a scalp-cooling system for prevention of hair loss and the experience of breast cancer patients treated by adjuvant chemotherapy.
  • Postmenopausal frontal fibrosing alopecia.
  • A method for evaluating and treating the temporal peak region in patients with male pattern baldness.
  • Lupus panniculitis clinically simulating alopecia areata.
  • Finasteride in the treatment of Taiwanese men with androgenetic alopecia: a 12-month open-label study.
  • Relationship between irreversible alopecia and exposure to cyclophosphamide, thiotepa and carboplatin (CTC) in high-dose chemotherapy.
  • Hair loss during treatment with oral contraceptives
  • Notch/RBP-J Signaling Regulates Epidermis/Hair Fate Determination of Hair Follicular Stem Cells.
  • Fas and c-kit are involved in the control of hair follicle melanocyte apoptosis and migration in chemotherapy-induced hair loss.
  • The potential role of minoxidil in the hair transplantation setting.
  • Finasteride in the treatment of Taiwanese men with androgenetic alopecia: a 12-month open-label study.
  • Acute Diffuse and Total Alopecia of the Female Scalp. a new subtype of diffuse alopecia areata that has a favorable prognosis.
  • Acute Diffuse and Total Alopecia of the Female Scalp. a new subtype of diffuse alopecia areata that has a favorable prognosis.
  • Dense-packing hair grafting technique for restoration of cicatricial alopecia
  • Role of the Autoimmune Regulator (AIRE) gene in alopecia areata: Strong association of a potentially functional AIRE polymorphism with alopecia universalis.
  • Alopecia areata in children: a clinical profile.
  • The pattern and profile of alopecia areata in Singapore - a study of 219 Asians.
  • Notch/RBP-J Signaling Regulates Epidermis/Hair Fate Determination of Hair Follicular Stem Cells.
  • Seventeen cases of alopecia areata: combination of SADBE topical immunotherapy with other therapies.
  • 'Cyclic alopecia' in Msx2 mutants: defects in hair cycling and hair shaft differentiation.
  • Female pattern hair loss.
  • Implication of VEGF, steroid hormones and neuropeptides in hair follicle cell responses
  • Dense-packing hair grafting technique for restoration of cicatricial alopecia
  • Postmenopausal frontal fibrosing alopecia.
  • There is no clear association between low serum ferritin and chronic diffuse telogen hair loss.
  • Striae distensae - like lesions. A cause of scarring alopecia among children.
  • Hair Transplantation for Men with Advanced Degrees of Hair Loss



    Hair loss and hair growth online references:

    1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 |